Skip to main content

Title

The natural and directed evolution of the molecular toolkit of stem cells

Date & Place

September 3, 2026, 9:15 AM
2 Hankiewicza Street, 02-103 Warsaw

About the event

SOX, OCT and KLF are pioneer transcription factors that control cell identity and can direct cell-lineage conversion, including the generation of induced pluripotent stem cells (iPSCs). We investigate both the evolutionary origins and the engineering potential of this molecular toolkit of stem cells. Our work showed that the evolutionary roots of SOX and OCT/POU factors predate animal multicellularity: an ancestral SOX protein, more than 700 million years old, can functionally replace mammalian SOX2 during pluripotency reprogramming. Guided by sequence analysis, structure-based design and directed evolution in mammalian cells, we redesign SOX, OCT and KLF factors to control cell fate more efficiently. These variants display altered molecular interactions, improved chromatin access and enhanced gene activation. For example, engineered SOX17 (eSOX17) accelerates pluripotency induction across species and promotes cell states with features of totipotency. Further, eSOX17 directly converts human blood cells into induced neural stem cells, bypassing pluripotency. These cells retain aspects of donor age, revealing amyotrophic lateral sclerosis-associated phenotypes that are obscured after pluripotent reprogramming. I will discuss how protein and cell engineering can illuminate mechanisms of ageing-associated disease, rejuvenate cells and provide a testbed for therapeutic intervention.

Speaker

Prof. Ralf Jauch

The University of Hong Kong (HKU) and Centre for Translational Stem Cell Biology (CTSCB)
Ralf Jauch is a tenured full Professor at the University of Hong Kong and Associate Director (Knowledge Exchange and Global) at the School of Biomedical Sciences. Dr. Ralf Jauch joined HKUMed in 2018 and established a multidisciplinary research program at the interface of protein engineering and stem cell biology. He is known for his contributions to improving the quality, utility, and efficiency of stem cell generation through the re-engineering of pioneer transcription factors and the study of their evolution. His current research focuses on age-related diseases and rejuvenation, as well as the natural and directed evolution of the molecular toolkit of stem cells. He completed his undergraduate studies at the Universities of Jena, Germany, and Manchester, and obtained his Ph.D. in Structural Biology from the International Max Planck Research School in Göttingen. In 2006, he moved to Asia to join the Genome Institute of Singapore, where he developed a passion for stem cells and protein design. In 2013, he joined the Guangzhou Institute of Biomedicine and Health in Mainland China as a Principal Investigator, where he established the GIBH-Max Planck Center for Regenerative Medicine and served as its deputy director. Dr. Jauch works to translate stem technologies at the Centre for Translational Stem Cell Biology (Health@InnoHK).

RACE project: RNA and Cell Biology – from Fundamental Research to Therapies

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.